An observational study in Elbow Flexion, Reanimation and Traumatic Brachial Plexus Injury, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged Up to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Tanta University · Observational
This study aimed to evaluate the effectiveness of different techniques in the restoration of elbow flexion in post-traumatic brachial plexus patients as regards timing and degree of recovery.
Traumatic brachial plexus injuries (BPI) are devastating life-altering events, with pervasive detrimental effects on a patient's physical, psychosocial and financial well-being. A full spectrum of techniques including neurolysis, nerve grafting, nerve transfers, free functional muscle transfers, tendon transfers, and joint arthrodesis.
Restoration of elbow flexion is an important goal in the treatment of patients with traumatic brachial plexus injury (BPI). The majority of patients with traumatic BPIs have injuries to the proximal elements of the spinal nerve roots or rootlets, which needs interposition nerve grafting. To restore elbow flexion in patients with preganglionic or avulsion injuries nerve transfers are a valuable option. Consequently, neurotization is frequently used as the primary reconstruction option in patients with deficient elbow flexion following traumatic BPIs.
Tanta University is the lead sponsor of 991 studies on the registry; 316 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
This prospective study was carried out on 30 patients admitted to neurosurgery department Faculty of Medicine, Tanta University and Mansoura university in the period from April 2023 to August 2025 presented with post-traumatic brachial plexus injury with failed conservative measurements for at least three months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with traumatic brachial plexus injury affecting elbow flexion who underwent Oberlin nerve transfer.
Procedure: Oberlin Nerve Transfer
Patients with traumatic brachial plexus injury affecting elbow flexion who underwent intercostal nerve transfer.
Procedure: Intercostal Nerve Transfer
Patients with traumatic brachial plexus injury affecting elbow flexion who underwent Oberlin nerve transfer. A motor fascicle of the ulnar nerve supplying the flexor carpi ulnaris was transferred to the biceps motor branch of the musculocutaneous nerve using tension-free microsurgical sutures reinforced with fibrin glue. Patients underwent postoperative immobilization followed by individualized rehabilitation and clinical assessment of elbow flexion recovery using the Medical Research Council muscle strength scale.
Patients with traumatic brachial plexus injury affecting elbow flexion who underwent intercostal nerve transfer. Two intercostal nerves were harvested, passed through a subcutaneous axillary tunnel, and transferred to the biceps motor branch of the musculocutaneous nerve. Patients underwent postoperative immobilization followed by individualized rehabilitation and clinical assessment of elbow flexion recovery using the Medical Research Council muscle strength scale.
Assessment of Elbow Flexion Muscle Strength
Postoperative elbow flexion muscle strength assessed using the Medical Research Council (MRC) scale and compared between the Oberlin nerve transfer and intercostal nerve transfer cohorts. Scores range from 0 (no muscle contraction) to 5 (normal muscle strength), with higher scores indicating better recovery. Useful motor recovery is defined as an MRC grade of 3 or higher, indicating elbow flexion against gravity.
Time frame: 24 months after surgery
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.